Lyme Disease Biobank Foundation
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2015 | 200,000 | 196,526 | 3,474 | 0.2 | 21% |
| 2016 | 760,644 | 416,500 | 344,144 | 8.6 | 31% |
| 2017 | 585,981 | 622,307 | −36,326 | 5.0 | 20% |
| 2018 | 596,017 | 683,588 | −87,571 | 3.0 | 22% |
| 2019 | 875,059 | 993,300 | −118,241 | 0.7 | 18% |
| 2020 | 778,814 | 817,600 | −38,786 | 0.2 | 18% |
| 2021 | 737,856 | 898,459 | −160,603 | -1.9 | 17% |
| 2022 | 1,014,899 | 956,573 | 58,326 | -1.1 | 19% |
| 2023 | 829,117 | 729,222 | 99,895 | 0.2 | 23% |
In its most recent public year (2023), this organization brought in $99,895 more than it spent. Its reserves stood at about 0.2 months of spending. Staff pay was 23% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works